Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.0B | 2.4B | 1.8B | 2.0B |
Cost of revenue | 1.7B | 2.0B | 1.6B | 1.7B |
Gross profit | 308.7M | 361.4M | 262.2M | 313.9M |
Operating expense | ||||
Research & development | 59.2M | 116.5M | 59.7M | 70.4M |
Selling general and admin | 83.1M | -132.7M | 197.9M | -33.2M |
Other operating expenses | 6.4M | 10.8M | -2.5M | 15.4M |
Operating income | 164.0M | 175.9M | 140.5M | 157.1M |
Non operating interest income | ||||
Income | 16.7M | 26.9M | 18.2M | 6.3M |
Expense | 2.0M | 2.5M | 2.9M | 2.9M |
Other income expense | — | — | — | — |
Pretax income | 176.7M | 142.9M | 147.1M | 149.9M |
Tax provision | 39.4M | 3.2M | 21.4M | 11.2M |
Net income | 137.3M | 139.7M | 125.7M | 138.6M |
Basic EPS | 0.3 | — | — | — |
Diluted EPS | 0.3 | — | — | — |
Basic average shares | 516.5M | — | — | — |
Diluted average shares | 516.5M | — | — | — |
EBITDA | 178.9M | 178.1M | 147.5M | 154.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | -8.2M | -13.4M | -8.6M | -9.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |